CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,230,000 | 4.40% |
| Palo Alto Investors LP | 4,484,411 | $20,000,000 | 1.21% |
| Ikarian Capital, LLC | 1,112,669 | $4,963,000 | 0.35% |
| Versant Venture Management, LLC | 101,855 | $454,000 | 0.19% |
| EMFO, LLC | 45,500 | $203,000 | 0.18% |
| Antara Capital LP | 510,000 | $2,275,000 | 0.17% |
| Virtus ETF Advisers LLC | 36,410 | $162,000 | 0.07% |
| PINNACLE ASSOCIATES LTD | 661,191 | $2,949,000 | 0.05% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,500 | $230,000 | 0.05% |
| Virtu Financial LLC | 105,562 | $471,000 | 0.04% |